NCT03110185

Brief Summary

In this study, we propose to use EEG and a brain imaging technique known as diffuse optical tomography (DOT) to study when people are in delirium and when they recovery. We plan to also compare brain function of patients who recovered from delirium to patients who did not have delirium using DOT and fMRI. We will also continually monitor the participant's EMR to help coordinate timing of study procedures, as well as to collect information pertaining to their surgery, recovery progress, and indicators of mental status including delirium.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 25, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2016

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

April 12, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2019

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

June 2, 2020

Completed
Last Updated

June 2, 2020

Status Verified

May 1, 2020

Enrollment Period

3.3 years

First QC Date

January 14, 2016

Results QC Date

February 12, 2020

Last Update Submit

May 23, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • EEG During Delirium and After Recovery and in Patient Controls.

    Delta (0.5-4 Hz), theta (4-8 Hz), and alpha (8-12 Hz) EEG waveforms.

    Data acquisition will occur on 4 separate days between postoperative days 1-8.

  • Functional Connectivity Diffuse Optical Tomography (fcDOT) in Patients During Delirium and After Recovery and in Patient Controls

    Functional connectivity between anterior and posterior Default Mode Network regions using diffuse optical imaging.

    Data acquisition will occur on 4 separate days between postoperative days 1-8.

  • Functional Connectivity Magnetic Resonance Imaging (fcMRI) in Patients After Recovery From Delirium and in Patient Controls.

    Functional connectivity between anterior and posterior Default Mode Network regions assessed from resting-state fcMRI acquired during eyes open wakefulness. Scored using r-value, using a scale of -1 to +1. -1 = strong negative correlation, +1 = strong positive correlation

    Within one month after hospital discharge.

Study Arms (2)

delirium

OTHER

Patients in the cardiothoracic ICU diagnosed with postoperative delirium. Subjects will wear a diffuse optical tomography device in addition to the normal monitors. A non-contrast functional MRI will be performed.

Device: EEGDevice: fcDOTDevice: fcMRI

no delirium

OTHER

Patients in the cardiothoracic ICU not diagnosed with postoperative delirium. Subjects will be monitored in the same way as the delirium arm

Device: EEGDevice: fcDOTDevice: fcMRI

Interventions

EEGDEVICE

Brain activity will be recorded to evaluate differences in brain activity between patients with a delirium diagnosis and non-delirious control patients.

Also known as: brain monitoring in delirious postoperative patients
deliriumno delirium
fcDOTDEVICE

Brain activity will be recorded to evaluate differences in brain activity between patients with a delirium diagnosis and non-delirious control patients.

Also known as: brain monitoring in delirious postoperative patients
deliriumno delirium
fcMRIDEVICE

Brain activity will be recorded to evaluate differences in brain activity between patients with a delirium diagnosis and non-delirious control patients.

Also known as: brain monitoring in delirious postoperative patients
deliriumno delirium

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 60
  • Surgery requiring cardiopulmonary bypass (CPB) for coronary artery bypass grafting, septal myectomy and/or heart valve repair/replacement
  • English speaking.

You may not qualify if:

  • Implanted pacemaker
  • Automatic internal cardiac defibrillator or other implant for which non-contrast magnetic resonance imaging (MRI) is contraindicated
  • Concomitant aortic or cerebrovascular procedure
  • Inability to lay flat or still for MRI
  • Legal blindness or severe deafness
  • Seizure history
  • Known focal brain lesion larger than 3 cm.
  • Delirium Case Arm:
  • \. Delirious as diagnosed by the Confusion Assessment Method (CAM)/ Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) at some point during postoperative day 1-5.
  • Postoperative Control Arm:
  • \. Not delirious as diagnosed by the CAM/CAM-ICU on postoperative day 1-5.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barnes-Jewish Hospital/Washington University in St. Louis School of Medicine

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

DeliriumPostoperative Complications

Interventions

Electroencephalography

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersPathologic Processes

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Results Point of Contact

Title
Dr. Ben Palanca
Organization
Washington University School of Medicine Department of Anesthesiology

Study Officials

  • Ben Palanca, MD, PhD, MSc

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 14, 2016

First Posted

April 12, 2017

Study Start

November 25, 2015

Primary Completion

March 8, 2019

Study Completion

March 8, 2019

Last Updated

June 2, 2020

Results First Posted

June 2, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations